Arkom Cheirsilpa

Direktor/Vorstandsmitglied bei THAI NAKARIN HOSPITAL

76 Jahre

Consumer Services

Health Services

Miscellaneous

Profil

Arkom Cheirsilpa is a professional with an MBA from the University of Chulalongkorn and an undergraduate degree from Mahidol University.
He is currently a Non-Executive Director & Director-Holistic at Thai Nakarin Hospital Public Co. Ltd.
since 2008.
Prior to this, he was the Deputy Director at National Cancer Institute from 2002 to 2007.

Aktive Positionen von Arkom Cheirsilpa

Unternehmen	Position	Beginn
THAI NAKARIN HOSPITAL	Direktor/Vorstandsmitglied	20.11.2008

Alle aktiven Positionen von Arkom Cheirsilpa

Ehemalige bekannte Positionen von Arkom Cheirsilpa

Unternehmen	Position	Ende
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	01.01.2007

Sehen Sie sich die Erfahrung von Arkom Cheirsilpa im Detail an

Ausbildung von Arkom Cheirsilpa

Mahidol University	Undergraduate Degree
University of Chulalongkorn	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Arkom Cheirsilpa im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
THAI NAKARIN HOSPITAL	Health Services

Private Unternehmen	1
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Miscellaneous